| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |